Results 131 to 140 of about 5,127 (197)

A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention. [PDF]

open access: yesJ Headache Pain
Antinew J   +7 more
europepmc   +1 more source

The Second Exteroceptive Suppression Period of the Temporalis Muscle Is Altered in Migraine Patients with Allodynia. [PDF]

open access: yesNeurol Int
Rota E   +6 more
europepmc   +1 more source

Lifetime classic psychedelic use and headaches: A cross-sectional study. [PDF]

open access: yesJ Psychopharmacol
Bjurenfalk Z   +3 more
europepmc   +1 more source

Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice. [PDF]

open access: yesACS Pharmacol Transl Sci
Effinger DP   +8 more
europepmc   +1 more source

Fibrosing Mediastinitis Caused by Histoplasmosis in an Adolescent. [PDF]

open access: yesJACC Case Rep
Ganigara M   +8 more
europepmc   +1 more source

Robust serotonin activation of the kisspeptin GnRH pulse generator in male and female mice.

open access: yesEndocrinology
Morris PG   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy